STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (17,699,998)	$ (3,023,617)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	108,143	223,863
Issuance of common stock, warrants and options for services	344,518	155,022
Modification of warrants issued for services	76,991	0
Equity based compensation	1,030,429	1,523,349
Common stock contributed to 401 (k) plan	76,709	79,709
Impairment loss on abandonment of patents	240	10,651
Loss on retired equipment	0	3,844
Loss (gain) on derivative instruments	5,521,531	(6,284,462)
(Increase)/decrease in assets:
Receivables	(60,686)	119,055
Deferred rent	373,460	274,569
Prepaid expenses	(144,072)	214,679
Inventory used for R&D and manufacturing	(404,439)	97,708
Deposits	(200,000)	0
Increase/(decrease) in liabilities:
Accounts payable	(547,868)	(150,880)
Accrued expenses	387,120	40,084
Deferred revenue	46	45
Due to employees	(34,367)	42,702
Deferred rent liability	(1,497)	664
Net cash used in operating activities	(11,173,740)	(6,673,015)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of equipment	(27,418)	(76,835)
Expenditures for patent costs	(25,166)	(10,136)
Net cash used in investing activities	(52,584)	(86,971)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	19,285,577	9,807,375
Proceeds from exercise of warrants	2,508,815	0
Payments on oblgations under capital leases	(4,101)	(2,694)
Net cash provided by financing activities	21,790,291	9,804,681
NET INCREASE IN CASH AND CASH EQUIVALENTS	10,563,967	3,044,695
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	41,612	3,941,042
CASH AND CASH EQUIVALENTS, END OF PERIOD	10,605,579	6,985,737
ISSUANCE OF WARRANTS:
Increase in derivative liabilities	(7,321,071)	(4,200,000)
Decrease in additional paid-in capital	7,321,071	4,200,000
Total	0	0
ISSUANCE OF ADDITIONAL SHARES
Increase in common stock	(15,631)	0
Increase in additional paid-in capital	(1,101,786)	0
Decrease in additional paid-in capital	1,117,417	0
Total	0	0
EXERCISE OF WARRANTS
Increase in common stock	(657)	0
Increase in additional paid-in capital	(974,486)	0
Decrease in derivative liabilities	975,143	0
Total	0	0
RECLASSIFICATION OF WARRANTS FROM LIABILITY TO EQUITY
Increase in additional paid-in capital	(1,308,528)	0
Decrease in derivative liabilities	1,308,528	0
Total	0	0
ISSUANCE OF COMMON STOCK FOR PREPAID SERVICES:
Increase in additional paid-in capital	(41,995)	(176,628)
Increase in prepaid expenses	41,995	176,628
Total	0	0
ISSUANCE OF COMMON STOCK FOR PATENT COSTS
Increase in common stock	(87)	0
Increase in additional paid-in capital	(9,912)	0
Increase in patent costs	9,999	0
Total	0	0
PATENT COSTS INCLUDED IN ACCOUNTS PAYABLE
(Decrease)/increase in patent costs	(14,024)	9,890
Decrease/(increase) in accounts payable	14,024	(9,890)
Total	0	0
NON-CASH EQUIPMENT COSTS
Increase in research and office equipment	(1,521)	49,413
Increase in accounts payable	(1,898)	(12,791)
Increase in capital lease obligation	3,419	(36,622)
Total	0	0
CAPITAL LEASE PAYMENTS INCLUDED IN ACCOUNTS PAYABLE:
Decrease in capital lease obligation	37	1,150
Increase in accounts payable	(37)	(1,150)
Total	0	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash expenditures for interest expense	$ 97,911	$ 84,210